Iodotubercidin And Abt

PDF A Head

Abt -702 and 5-Iodotubercidin are both potent inhibitors of adenosine kinase, but they present distinct pharmacological profiles. Abt -702 is a highly selective, non-nucleoside inhibitor with well-documented analgesic and anti-inflammatory effects in preclinical models.[5][9][12] Its high selectivity suggests a lower potential for off-target effects.

Small molecule screening studies found that WS6, 5-iodotubercidin, and ABT -702 can stimulate beta cell proliferation (Table 6.8). WS6 may induce this effect through activating Erb3 and the I kappa B kinase pathway [114], whereas the other two small molecules promote beta cell proliferation through inhibiting adenosine kinase [115].

PDF Preparation of 5131Iiodotubercidin for the detection of adenosine

In the landscape of adenosine kinase (AK) inhibitors, both ABT -702 dihydrochloride and 5-Iodotubercidin have emerged as significant compounds of interest for researchers in drug development and cellular signaling. While both molecules effectively inhibit adenosine kinase, their distinct pharmacological profiles, selectivity, and mechanisms of action warrant a detailed comparative analysis ...

5 Iodotubercidin

Abstract Aims Tuberculosis (TB) remains a major global health threat, underscoring the urgent need for novel therapeutics. 5-Iodotubercidin (5-ITu), a purine-based protein kinase inhibitor, has not been previously evaluated for anti-tuberculosis (anti-TB) applications.